Kanzaki, Masato
Takagi, Ryo
Washio, Kaoru
Kokubo, Mami
Mitsuboshi, Shota
Isaka, Tamami
Yamato, Masayuki http://orcid.org/0000-0002-3146-1024
Article History
Received: 19 October 2019
Accepted: 20 November 2020
First Online: 4 January 2021
Competing interests
: Dr. Masayuki Yamato has equity financial interest in CellSeed, Tokyo, Japan, a publicly-traded Japanese biotechnology company exclusively developing cell sheet technology for regenerative medicine purposes. The remaining authors declare no competing interests.